Last reviewed · How we verify
FERRIC OXYHYDROXIDE
At a glance
| Generic name | FERRIC OXYHYDROXIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
Common side effects
Key clinical trials
- Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women (PHASE4)
- Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FERRIC OXYHYDROXIDE CI brief — competitive landscape report
- FERRIC OXYHYDROXIDE updates RSS · CI watch RSS